126 related articles for article (PubMed ID: 20450746)
21. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
22. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
24. Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis.
Wei WJ; Wang YL; Li DS; Wang Y; Wang XF; Zhu YX; Yang YJ; Wang ZY; Ma YY; Wu Y; Jin L; Ji QH; Wang JC
PLoS One; 2013; 8(2):e56638. PubMed ID: 23451063
[TBL] [Abstract][Full Text] [Related]
25. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
Park SH; Lee GY; Jeon HS; Lee SJ; Kim KM; Jang SS; Kim CH; Lee WK; Kam S; Park RW; Kim IS; Jung TH; Park JY
Int J Cancer; 2004 Nov; 112(4):678-82. PubMed ID: 15382050
[TBL] [Abstract][Full Text] [Related]
26. [Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].
Lu XX; Ge MH; Ling ZQ; Hu SS; Xu J; Zheng CM; Tan Z; Chen C
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):833-6. PubMed ID: 24447481
[TBL] [Abstract][Full Text] [Related]
27. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
Mu G; Wang H; Cai Z; Ji H
Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349
[TBL] [Abstract][Full Text] [Related]
28. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
29. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
[TBL] [Abstract][Full Text] [Related]
30. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
[TBL] [Abstract][Full Text] [Related]
31. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
32. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG
J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
34. Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.
Nizam ZM; Abdul Aziz AA; Kaur G; Abu Hassan MR; Mohd Sidek AS; Yeh LY; Mazuwin M; Ankathil R
Asian Pac J Cancer Prev; 2013; 14(2):619-24. PubMed ID: 23621208
[TBL] [Abstract][Full Text] [Related]
35. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
36. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma.
Ge M; Shi M; An C; Yang W; Nie X; Zhang J; Lv Z; Li J; Zhou L; Du Z; Yang M
Sci Rep; 2016 May; 6():26037. PubMed ID: 27185198
[TBL] [Abstract][Full Text] [Related]
37. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.
Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K
Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979
[TBL] [Abstract][Full Text] [Related]
38. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
39. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene.
Bagnoli S; Putignano AL; Melean G; Baglioni S; Sestini R; Milla M; d'Albasio G; Genuardi M; Pacini F; Trallori G; Papi L
Inflamm Bowel Dis; 2004 Nov; 10(6):705-8. PubMed ID: 15626886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
